STAT3 and prostate carcinoma: We first evaluated the protein levels of PLZF and Tyr705 phosphorylation STAT3 (pY-STAT3) in 40 prostate cancer patients and 10 benign patient tissues, which were categorized according to Gleason scores (GS).